We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Observational analysis reveals efficacy of second-line treatments in advanced EGFR-mutated lung cancer, suggesting potential therapeutic options.
No takes yet. Share an insight, caveat, or question.
Lajoinie et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: